Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Sertraline, an antidepressant, may rarely cause hair loss.

Sertraline, an antidepressant, may cause hair loss in rare cases.

Venlafaxine can cause hair loss, which stops after discontinuation.

If a child is losing a lot of eyelashes and it keeps happening, doctors should look carefully at their health history because it might be a sign of a different health problem.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

Most dermatologists in Western Rajasthan prefer the anti-depressant Doxepin for elderly skin conditions and often refer patients to a psychiatrist.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Some psychotropic medications can rarely cause hair loss, and stopping these drugs usually reverses the condition.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

Emotional factors are crucial in treating and preventing scalp neurodermatitis and hair loss.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Stopping the antidepressant agomelatine improved hair loss in a patient.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.